Related Experiment Video

Updated: Aug 24, 2026

A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
07:38

A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s

Published on: September 25, 2017

Carcinogenicity and mutagenicity of nickel and nickel compounds

A Reith, A Brøgger

    IARC Scientific Publications
    |January 1, 1984
    PubMed

    Insights

    Carcinogenic nickel compounds can cause mutations, but their efficacy is low. Caution is needed when extrapolating short-term test results to long-term human exposure, as nickel may also promote tumors.

    Area of Science:

    • Toxicology
    • Environmental Health
    • Cancer Research

    Background:

    • Tumor development involves complex mechanisms.
    • Genotoxicity tests are crucial for assessing chemical hazards.
    • Nickel compounds are known carcinogens with potential genotoxic effects.

    Purpose of the Study:

    • To summarize mutagenicity testing data for nickel compounds.
    • To evaluate the role of nickel in tumor initiation and promotion.
    • To assess the predictive value of genotoxicity tests for nickel exposure.

    Main Methods:

    • Review of existing data on nickel mutagenicity.
    • Analysis of genotoxicity test results (e.g., chromosome breakage).
    • Consideration of experimental transformation studies.

    Main Results:

    • Carcinogenic nickel compounds can induce mutations like chromosome damage.
    • The mutagenic efficacy of nickel compounds is generally low compared to organic mutagens.
    • Nickel compounds may possess tumor-promoting properties.
    • Short-term mutation tests have limitations for predicting long-term human cancer risk.

    Conclusions:

    • While nickel compounds show mutagenic potential, their low efficacy and the limitations of short-term tests necessitate caution in risk assessment.
    • Positive genotoxicity findings indicate a carcinogenic hazard, but negative results do not rule out risk.
    • Nickel compounds may contribute to cancer development through both initiation (mutagenesis) and promotion.

    More Related Videos

    Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling09:33

    Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

    Published on: March 20, 2018

    The Lambda Select cII Mutation Detection System07:08

    The Lambda Select cII Mutation Detection System

    Published on: April 26, 2018

    Related Concept Videos

    Cancer Prevention02:59

    Cancer Prevention

    Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
    Some...
    Physical Properties of Amines01:26

    Physical Properties of Amines

    Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
    Mutagenicity and Carcinogenicity01:25

    Mutagenicity and Carcinogenicity

    Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
    Bioactivation and Tissue Toxicity01:25

    Bioactivation and Tissue Toxicity

    Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
    Toxicity Testing in Animals01:23

    Toxicity Testing in Animals

    Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
    Spontaneous and Induced Mutations01:30

    Spontaneous and Induced Mutations

    Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).